Presentations & Publications

Effects of ADXS-PSA in Combination With Pembrolizumab on Survival in Metastatic,Castration-Resistant Prostate Cancer Patients With or Without Prior Exposure to Docetaxel

UPLOADED:

February 12, 2020

Effects of ADXS-PSA With or Without Pembrolizumab on Survival and Antigen Spreading in Metastatic, Castration-Resistant Prostate Cancer Patients (Results from KEYNOTE-046)

UPLOADED:

May 13, 2019

Safety and Immunogenicity of a Personalized Neoantigen-Listeria Vaccine in Cancer Patients

UPLOADED:

May 13, 2019

KEYNOTE-046 AACR 2019 Abstract

UPLOADED:

April 1, 2019

AACR2019-keynote-046-adxs-psa-plus-pembrolizumab-metastatic-castration-resistant-prostate-cancer

UPLOADED:

January 4, 2019

KEYNOTE-046: ADXS-PSA Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

UPLOADED:

May 30, 2018

Tolerability of ADXS11-001 Lm-LLO Listeria Based Immunotherapy With Mitomycin, Fluorouracil and Radiation for Anal Cancer

UPLOADED:

April 1, 2018

Combination TIGIT blockade with Listeria-based immunotherapy enhances antigen-specific antitumor immunity

UPLOADED:

March 25, 2018

Agonism of the CD137 co-stimulatory pathway synergizes with the Listeria monocytogenes-based immunotherapy, axalimogene filolisbac, to promote durable tumor regression in a murine HPV+ tumor model

UPLOADED:

March 25, 2018

Targeting of CCR8 induces antitumor activity as a monotherapy that is further enhanced in combination with a Listeria-based immunotherapy

UPLOADED:

March 25, 2018

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases and Advaxis' breaking news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.